|
Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis |
13-Jan |
|
|
|
|
A Low‐Cost Tebuconazole‐Based Screening Test for Azole‐Resistant Aspergillus fumigatus |
02-Sep |
Article |
|
|
|
Use of omalizumab in fungal allergic asthma |
02-Sep |
|
|
|
|
Outdoor fungal spore levels, lung function and symptoms in patients with asthma and aspergillus sensitisation |
02-Sep |
|
|
|
|
Prevalence and clinical outcomes of fungal sensitive asthma in a severe asthma population |
02-Sep |
|
|
|
|
Fungal contamination of valved holding chambers (VHCS): potential to prevent, and effect on drug delivery |
02-Sep |
|
|
|
|
Insufficient allergy diagnostics in severe asthmatic patients in Germany |
02-Sep |
|
|
|
|
Species distribution patterns and epidemiological characteristics of otomycosis in Southeastern Serbia |
02-Sep |
Article |
|
|
|
Environmental fungal sensitisation associates with poorer clinical outcomes in COPD |
02-Sep |
Article |
|
|
|
The contribution of Aspergillus fumigatus to COPD exacerbations: a "sensitive" topic |
02-Sep |
Article |
|
|
